Clinical Trial

Dupilumab De-escalation in Pediatric Atopic Dermatitis

Name: Dupilumab De-escalation in Pediatric Atopic Dermatitis — clinical trial record (NCT06116526)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This is a pilot investigator-blinded, randomized clinical trial to assess the feasibility of dupilumab treatment discontinuation or dose-reduction in children aged 1-17 years who have achieved sustained atopic dermatitis (AD) control on dupilumab.

Protocol Amendment History 1 change

notable Primary completion pushed: 2026-04-01 -> 2027-04-01 2026-04-21

Trial Details

NCT Number	NCT06116526
Lead Sponsor	Johns Hopkins University Collaborators: Doris Duke Charitable Foundation
Conditions	Atopic Dermatitis
Enrollment	30 participants
Start Date	2024-04-01
Primary Completion	2027-04-01 (estimated)
Study Completion	2027-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-20